ADAMTS13 and thrombotic thrombocytopenic purpura: Reduced ADAMTS13 activity in TTP is caused by genetic mutations or inhibitory autoantibodies, leading to congenital (cTTP) or immune-mediated (iTTP), respectively [7,8].